Air India tests 5,000+ pilots as DGCA weighs annual drug screening

Following a positive marijuana test involving an Air India captain after an August Phuket-Delhi incident, the airline has begun one-time mandatory testing of more than 5,000 pilots. The DGCA is consulting on rules that could extend annual random testing to all pilots.

— Source publishedTue, 25 Aug, 2026, 13:47 IST·First seen Tue, 25 Aug, 2026, 14:03 IST·Source Indian Express · Business

What happened

After an Air India captain tested positive for marijuana following an August 4 Phuket-Delhi altitude-drop incident, MoCA proposed annual testing of all pilots.

Key facts

  • Annual random drug testing currently covers 10% of pilots
  • MoCA suggests annual testing of 100% of pilots
  • Air India has begun one-time mandatory testing of more than 5,000 pilots
  • FIP proposed raising annual testing coverage to 25%
  • The August 4 flight dropped about 300 feet
  • 20 passengers and 4 cabin crew were injured
  • 17 of 24 injured people were hospitalised
  • The aircraft carried 137 passengers, 6 cabin crew and 2 pilots
  • A second positive test can result in a three-year licence suspension

Why this matters

Any aviation, airport, or travel-services partnership in India should now diligence drug-testing compliance capabilities, workforce availability, and exposure to tougher DGCA disciplinary rules.

What to watch

  • DGCA consultation paper, final rule, testing frequency, substances covered and effective date
  • Number and seniority of pilots testing positive, suspended or cleared after confirmatory testing
  • Air India cancellation, delay, crew-shortage and wet-lease indicators during the testing rollout
  • Pilot union response, litigation risk and privacy or due-process objections
  • Accredited laboratory capacity, test turnaround times and chain-of-custody standards
  • Whether IndiGo, Akasa Air, SpiceJet and Vistara-era Air India operations announce comparable programs
  • Safety-rating, insurer or corporate-travel-policy changes tied to drug-testing compliance
  • Air India is likely to complete its pilot testing drive, institute repeat testing for flagged or safety-sensitive cohorts, and tighten fitness-to-fly documentation.
  • DGCA is likely to seek airline, pilot-union, medical-lab and legal feedback before publishing revised testing and disciplinary rules.
  • Other Indian carriers may begin voluntary or expanded testing programs ahead of a final mandate to reduce reputational exposure.
  • Airlines may build additional reserve-crew buffers, increasing training, standby and rostering costs during implementation.
  • Travel retailers, airport concessionaires and corporate travel buyers may monitor cancellation and delay data, especially on Air India routes, for any operational spillover.